Search
for

    Sort by

    Research 841–870 of 1000+

    1. Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome Health and Quality of Life Outcomes · 2016 · 19 citations
    2. PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA) Clinical Endocrinology · 1980 · 6 citations
    3. Severe Hyperandrogenism in A Premenopausal Woman With An Imaging-Negative Leydig Cell Tumor AACE clinical case reports · 2020
    4. Hair loss in women 2011
    5. Risk of Abnormal Pregnancy Completing Chemotherapy for Gestational Trophoblastic Tumor Obstetrical & Gynecological Survey · 2003
    6. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertility and Sterility · 2008 · 1540 citations
    7. Ovarian hormones and adrenal androgens during a woman's life span Journal of The American Academy of Dermatology · 2001 · 24 citations
    8. Oral contraceptives and risk of breast cancer in women aged 20–54 years International Journal of Gynecology & Obstetrics · 1995
    9. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea International Journal of Gynecology & Obstetrics · 1995
    10. Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism European Journal of Clinical Investigation · 2011 · 39 citations
    11. Genetic basis of polycystic ovary syndrome Expert Review of Endocrinology & Metabolism · 2010 · 18 citations
    12. Urinary steroids in women with androgenic alopecia Clinical Biochemistry · 2000 · 16 citations
    13. Topical Antiandrogens Archives of Dermatology · 1985 · 11 citations
    14. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance Clinical Medicine · 2015 · 62 citations
    15. The Effect of Stromal Vascular Fraction for Patients with Androgenetic Alopecia Journal of the turkish academy of dermatology · 2020 · 3 citations
    16. An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report touchREVIEWS in Endocrinology · 2021
    17. Androgen excess is the key element in polycystic ovary syndrome Fertility and Sterility · 2003 · 99 citations
    18. Diagnosis of hyperandrogenism: clinical criteria Best Practice & Research Clinical Endocrinology & Metabolism · 2006 · 85 citations
    19. Hormonal treatment of acne vulgaris: an update Clinical, Cosmetic and Investigational Dermatology · 2016 · 46 citations
    20. Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism · 2016 · 40 citations
    21. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare Reproductive Biology and Endocrinology · 2012 · 39 citations
    22. Hormonal Parameters in Androgenetic Hair Loss in the Male Dermatology · 2009 · 21 citations
    23. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis Clinical Endocrinology · 2017 · 20 citations
    24. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne International Journal of Dermatology · 2010 · 20 citations
    25. The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study Physiological Research · 2016 · 14 citations
    26. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women Taiwanese Journal of Obstetrics & Gynecology · 2018 · 13 citations
    27. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients Ginekologia Polska · 2017 · 9 citations
    28. Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome Fertility and Sterility · 2013 · 6 citations
    29. Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient International journal of reproduction, contraception, obstetrics and gynecology · 2017 · 3 citations
    30. POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE Anti-Aging Eastern Europe · 2024 · 2 citations